Clinical Trial

A Study in Patients With Mixed Dyslipidemia

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated January 13, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
A Phase 2 in Patients With Mixed Dyslipidemia
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2024-07-04; most recent amendment 2026-01-11.
Status change: Recruiting → Active, Not Recruiting 2026-01-09
Status change: Active, Not Recruiting → Recruiting 2025-08-14
Status change: Recruiting → Active, Not Recruiting 2025-06-25
Status change: Not Yet Recruiting → Recruiting 2024-12-16
Trial Details
NCT Number NCT06497127
Lead Sponsor Shanghai Argo Biopharmaceutical Co., Ltd.
Conditions Mixed Dyslipidemia
Enrollment 145 participants
Start Date 2024-02-28
Primary Completion 2026-06-30 (estimated)
Study Completion 2028-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-13